CIK 0001816736
- Large accelerated filer
Disc Medicine, Inc.
Sign in to watch- Ticker
- IRON
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 851612845
- Phone
- +1 617-674-9274
- Business address
- 321 ARSENAL STREET, SUITE 101, WATERTOWN, MA, 02472
- Former names
- Gemini Therapeutics, Inc. /DE, FS Development Corp.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $11,877,065
- in 6 filings, $10.0M under 10b5-1 plans
Net −$11,877,065. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 32 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-12-14 | Ashiya Mona Director | Sale | −100 | $57.73 | $6K | 727,807 |
| 2023-12-13 | Bitterman Kevin Director | Sale | −3,508 | $59.99 | $210K | 826,749 |
| 2023-12-13 | Bitterman Kevin Director | Sale | −40 | $60.50 | $2K | 826,709 |
| 2023-12-13 | Atlas Venture Fund X, L.P. 10% owner | Sale | −5,263 | $59.99 | $316K | 1,510,571 |
| 2023-12-13 | Atlas Venture Fund X, L.P. 10% owner | Sale | −3,508 | $59.99 | $210K | 826,749 |
| 2023-12-13 | Atlas Venture Fund X, L.P. 10% owner | Sale | −60 | $60.50 | $4K | 1,510,511 |
| 2023-12-13 | Atlas Venture Fund X, L.P. 10% owner | Sale | −40 | $60.50 | $2K | 826,709 |
| 2023-12-13 | ORBIMED ADVISORS LLC Director | Sale | −56,200 | $58.56 | $3.3M | 1,126,225 |
| 2023-12-13 | ORBIMED ADVISORS LLC Director | Sale | −36,400 | $58.56 | $2.1M | 727,907 |
| 2023-12-13 | ORBIMED ADVISORS LLC Director | Sale | −14,100 | $58.56 | $826K | 281,505 |
| 2023-12-13 | Ashiya Mona Director | Sale | −56,200 | $58.56 | $3.3M | 1,126,225 |
| 2023-12-13 | Ashiya Mona Director | Sale | −36,400 | $58.56 | $2.1M | 727,907 |
| 2023-12-13 | Ashiya Mona Director | Sale | −14,100 | $58.56 | $826K | 281,505 |
| 2023-12-12 | Bitterman Kevin Director | Sale | −20,823 | $59.87 | $1.2M | 861,401 |
| 2023-12-12 | Bitterman Kevin Director | Sale | −422 | $60.99 | $26K | 860,979 |
| 2023-12-12 | Bitterman Kevin Director | Sale | −4,155 | $62.42 | $259K | 856,824 |
| 2023-12-12 | Bitterman Kevin Director | Sale | −665 | $62.90 | $42K | 856,159 |
| 2023-12-12 | Bitterman Kevin Director | Sale | −688 | $63.78 | $44K | 855,471 |
| 2023-12-12 | Bitterman Kevin Director | Sale | −18,615 | $65.10 | $1.2M | 836,856 |
| 2023-12-12 | Bitterman Kevin Director | Sale | −6,599 | $65.77 | $434K | 830,257 |
Page 25 of 32 · 639 trades